Product Images Ciclopirox Olamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Ciclopirox Olamine NDC 69315-309 by Leading Pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton30ml - carton30ml

carton30ml - carton30ml

This is not readable text.*

carton60ml - carton60ml

carton60ml - carton60ml

The text is a description of a medicinal product containing Ciclopirox in a water-based suspension. It provides information about the quantity of Ciclopirox in each gram of the suspension, along with details about the ingredients in the suspension base. It also mentions the temperature at which the product should be stored. The remaining portions of the text appear to be nonsensical and may be the result of errors.*

image description - chemicalstructure

image description - chemicalstructure

containerlabel30ml - containerlabel30ml

containerlabel30ml - containerlabel30ml

This is a prescription-only topical suspension medication called Ciclopirox. It is not for use in the eyes and should be kept out of reach of children. The suspension is water-miscible and contains Ciclopirox Olamine as its active ingredient. It is to be applied twice daily and massaged into the affected and surrounding skin areas. This medication is manufactured for Leading Pharma LLC and made by Teigent Pharma Inc. It is advised to read the package insert for full prescribing information.*

containerlabel60ml - containerlabel60ml

containerlabel60ml - containerlabel60ml

This is a prescription drug with NDC (National Drug Code) number 69315-309-60. It is a 60 mL topical suspension of Ciclopirox that is meant for external use only and should not be applied to the eyes. The packaging includes cautionary instructions for keeping it out of reach of children. The manufacturer is identified as Leading Pharma, and the revision date of the medication's information is April 2020.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.